Skip to content

13F-HR filed by SUPERSTRING CAPITAL MANAGEMENT LP

SUPERSTRING CAPITAL MANAGEMENT LP filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 18:54:38 UTC, with 35 holding rows worth $199,517,915.

Accession
0001931118-26-000011
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 35 entries on the cover page, a total value of $199,517,915 stated on the cover page (in dollars after the unit check, H1), rows summing to $199,517,915 with VALUE read as dollars as filed, 13F file number 028-23866. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
COGENT BIOSCIENCES INC19240Q201COM597,408$19,129,004dollars as filed
AXSOME THERAPEUTICS INC. COM05464T104Stock102,485$18,897,209dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock984,892$14,103,653dollars as filed
GENMAB A/S372303206Ordinary Shares, nominal value DKK 1 per share365,662$13,044,992dollars as filed
CLIMB BIO INC28658R106COMMON STOCK918,231$10,532,110dollars as filed
ZAI LAB LTD ADR98887Q104ADR362,671$9,552,754dollars as filed
Adlai Nortye00704R109SPONSORED ADS588,418$9,414,688dollars as filed
REVOLUTION MEDICINES INC COM76155X100Stock41,784$8,576,584dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW242,493$7,859,198dollars as filed
IMMUNOVANT INC45258J102COM222,121$7,503,247dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK184,392$7,491,847dollars as filed
UNITED THERAPEUTICS CORP DEL COM91307C102Stock13,321$7,218,517dollars as filed
LEGEND BIOTECH CORP52490G102SPONSORED ADS357,359$7,107,871dollars as filed
DEFINIUM THERAPEUTICS INC24477V105COM SHS176,561$6,719,912dollars as filed
ROIVANT SCIENCES LTDG76279101SHS178,842$6,540,252dollars as filed
VIR BIOTECHNOLOGY INC92764N102COM578,696$6,469,821dollars as filed
IONIS PHARMACEUTICALS INC COM462222100Stock132,339$5,908,936dollars as filed
SAVARA INC805111101COM1,017,817$5,251,936dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK423,006$4,179,299dollars as filed
ABIVAX SA-00370M103SPONSORED ADS30,020$2,972,580dollars as filed
GINKGO BIOWORKS HOLDINGS INC37611X209COMMON STOCK222,553$2,855,355dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW30,022$2,672,859dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK48,045$2,393,602dollars as filed
KINIKSA PHARMACEUTICALS INTL P ORD SHS CL AG52694109Stock31,684$2,363,943dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK413,373$2,013,127dollars as filed
Latigo Biotherapeutics, Inc.517954103Common Stock, par value $0.0001 per share88,178$1,472,573dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock15,446$1,286,497dollars as filed
MAPLIGHT THERAPEUTICS INC56565P103COMMON STOCK118,304$1,205,518dollars as filed
MADRIGAL PHARMACEUTICALS INC COM558868105Stock2,099$1,057,812dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK517,412$993,431dollars as filed
XENON PHARMACEUTICALS INC COM98420N105Stock26,496$985,386dollars as filed
TONIX PHARMACEUTICALS HOLDIN890260839COMMON STOCK74,688$727,461dollars as filed
BOUNDLESS BIO INC10170A100COM206,242$517,667dollars as filed
GRAIL INC384747101COM3,238$453,709dollars as filed
BIOMEA FUSION INC09077A106CMN225,872$44,565dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001931118-26-000011this filing2026-11-16